To determine the influence of an initial treatment of 3 months with adalimumab, 40 mg every other week, in the percentage of patients achieving at 6 months (week 26), a decrease in their corticosteroid treatment to a dose equal or lower than 0,1 mg/kg 1 year [clinicaltrials_resource:a686a772efe20fd0d83bf8fd1f553c01]
placebo
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
To determine the influence of an initial treatment of 3 months with adalimumab, 40 mg every other week, in the percentage of patients achieving at 6 months (week 26), a decrease in their corticosteroid treatment to a dose equal or lower than 0,1 mg/kg 1 year [clinicaltrials_resource:a686a772efe20fd0d83bf8fd1f553c01]
placebo
Bio2RDF identifier
a686a772efe20fd0d83bf8fd1f553c01
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a686a772efe20fd0d83bf8fd1f553c01
measure [clinicaltrials_vocabulary:measure]
To determine the influence of ...... equal or lower than 0,1 mg/kg
time frame [clinicaltrials_vocabulary:time-frame]
description
identifier
clinicaltrials_resource:a686a772efe20fd0d83bf8fd1f553c01
title
To determine the influence of ...... or lower than 0,1 mg/kg 1 year
@en
type
label
To determine the influence of ...... 6a772efe20fd0d83bf8fd1f553c01]
@en